40 related articles for article (PubMed ID: 16699456)
1. Impact of Donor Source on the Outcome of Live Donor Kidney Transplantation: A Single Center Experience.
Matter YE; Nagib AM; Lotfy OE; Alsayed AM; Donia AF; Refaie AF; Akl AI; Abbas MH; Abuelmagd MM; Shaeashaa HA; Shokeir AA
Nephrourol Mon; 2016 May; 8(3):e34770. PubMed ID: 27570751
[TBL] [Abstract][Full Text] [Related]
2. Pediatric renal transplantation: a single center experience.
Said SHA; Agha SH; Abdulla GF; Jaafar MS; Bapir R; Hama NH; Aghaways I; Rashid AO; Abdalla BA; Kakamad FH
Arch Ital Urol Androl; 2024 May; ():12389. PubMed ID: 38767870
[TBL] [Abstract][Full Text] [Related]
3. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
[TBL] [Abstract][Full Text] [Related]
4. Induction with rATG versus No-induction in Deceased Donor Renal Transplantation - A Retrospective Observational Study.
Dwivedi R; Shashikiran KB; Manuel S; Ansari FA; Madipalli RT; Golla A; Raju SB
Indian J Nephrol; 2022; 32(5):423-429. PubMed ID: 36568588
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-inducible C-type lectin activates B cells to promote T cell reconstitution in heart allograft recipients.
Hasgur S; Yamamoto Y; Fan R; Nicosia M; Gorbacheva V; Zwick D; Araki M; Fairchild RL; Valujskikh A
Am J Transplant; 2022 Jul; 22(7):1779-1790. PubMed ID: 35294793
[TBL] [Abstract][Full Text] [Related]
6. Comparing the effect of induction therapy with or without antithymocyte globulin on renal allograft outcomes in live-donor kidney transplant recipients.
Marghoob B; Rahimian N; Ataiepour Y; Mahdifarani M; Nejatifar M; Kabir A
Med J Islam Repub Iran; 2019; 33():141. PubMed ID: 32280647
[No Abstract] [Full Text] [Related]
7. Antithymocyte Globulin: Indiscriminate Use and Complications.
Khan T; Mirza I; Anwar N
Ann Transplant; 2019 Nov; 24():605-607. PubMed ID: 31754089
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.
Ayasoufi K; Zwick DB; Fan R; Hasgur S; Nicosia M; Gorbacheva V; Keslar KS; Min B; Fairchild RL; Valujskikh A
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944247
[TBL] [Abstract][Full Text] [Related]
9. Perioperative effects of high doses of intraoperative thymoglobulin induction in liver transplantation.
De Pietri L; Serra V; Preziosi G; Rompianesi G; Begliomini B
World J Transplant; 2015 Dec; 5(4):320-8. PubMed ID: 26722660
[TBL] [Abstract][Full Text] [Related]
10. Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know.
Wiseman AC
Clin J Am Soc Nephrol; 2015 Jun; 10(6):923-5. PubMed ID: 25979977
[No Abstract] [Full Text] [Related]
11. New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity.
Mohty M; Bacigalupo A; Saliba F; Zuckermann A; Morelon E; Lebranchu Y
Drugs; 2014 Sep; 74(14):1605-34. PubMed ID: 25164240
[TBL] [Abstract][Full Text] [Related]
12. Adding thymoglobuline to the conventional immunosuppressant regimen in kidney transplantation: A cost-benefit analysis.
Oliaei F; Akbari R; Ghazi Mirsaeid AM
Caspian J Intern Med; 2012; 3(4):514-8. PubMed ID: 24009926
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Jayashankar K; Garcia SF; Abdel-Rasoul M; van Rooijen N; Bumgardner GL
Cell Transplant; 2013; 22(7):1157-69. PubMed ID: 23069206
[TBL] [Abstract][Full Text] [Related]
14. Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.
Gaber AO; Monaco AP; Russell JA; Lebranchu Y; Mohty M
Drugs; 2010 Apr; 70(6):691-732. PubMed ID: 20394456
[TBL] [Abstract][Full Text] [Related]
15. Thymoglobulin--new approaches to optimal outcomes.
Moicean AD; Popp AM; Sinescu I
J Med Life; 2009; 2(3):319-24. PubMed ID: 20112478
[TBL] [Abstract][Full Text] [Related]
16. Renal transplantation today.
Neipp M; Jackobs S; Klempnauer J
Langenbecks Arch Surg; 2009 Jan; 394(1):1-16. PubMed ID: 18478256
[TBL] [Abstract][Full Text] [Related]
17. Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience.
Hardinger KL; Schnitzler MA; Koch MJ; Labile E; Stirnemann PM; Miller B; Enkvetchakul D; Brennan DC
Transplantation; 2006 May; 81(9):1285-9. PubMed ID: 16699456
[TBL] [Abstract][Full Text] [Related]
18. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients.
Lim WH; Chang SH; Chadban SJ; Campbell SB; Dent H; Russ GR; McDonald SP
Transplantation; 2009 Nov; 88(10):1208-13. PubMed ID: 19935375
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
